Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1377842 | Bioorganic & Medicinal Chemistry Letters | 2006 | 4 Pages |
Abstract
A novel series of 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives has been prepared and their synthesis described herein. In vitro affinities for δ-, μ-, and κ-opioid receptors, as well as the functional activity in the [35S]GTPγS assay are reported. The most potent and selective δ-opioid agonist 18a exhibited a Ki of 18 nM, and was >258-fold and 28-fold selective over μ- and κ-receptors, respectively; the compound is a full agonist with an EC50 value of 14 nM.
Graphical abstractA new chemical class of selective δ-opioid agonists based on the 4-phenyl-4-[1H-imidazol-2-yl]-piperidine scaffold is reported. A highly selective δ agonist (18a, EC50 = 14 nM) was identified.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Andrés A. Trabanco, Shirley Pullan, José M. Alonso, Rosa M. Alvarez, José I. Andrés, Inge Boeckx, Javier Fernández, Antonio Gómez, Laura Iturrino, Frans E. Janssens, Joseph E. Leenaerts, Ana I. De Lucas, Encarna Matesanz, Theo Meert, Thomas Steckler,